Verona Pharma (VRNA) Broke Out To A New High On Study Results

Verona Pharma (VRNA) announced Monday morning that its Phase 2b study of RPL554 for the treatment of COPD met its primary endpoint.

from RTT - Before the Bell https://ift.tt/2GinyKE
via IFTTT